FDA gives big win to Amgen in biosimilars race

You are here: Home > Central Coast Health Watch > Current Article

By Philip Joens / Friday, September 30th, 2016 / Comments Off on FDA gives big win to Amgen in biosimilars race

Amgen co-founder William K. Bowes Jr. stands watch over the Thousand Oaks campus. Amgen is officially in the biosimilar game. The Food and Drug Administration approved the Thousand Oaks-biotech giant’s Humira biosimilar Sept. 23, making it the first Amgen biosimilar approved for sale anywhere in the world. The approval could be a windfall for the…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.